Neuromethods - Computational Modeling of Drugs Against Alzheimer’s Disease
Latest Publications

TOTAL DOCUMENTS

(FIVE YEARS 0)

H-INDEX

(FIVE YEARS 0)

Published By Springer New York

9781493974030, 9781493974047

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Recent Advances in Computational Approaches for Designing Potential Anti-Alzheimer’s Agents

Neuromethods - Computational Modeling of Drugs Against Alzheimer’s Disease ◽

10.1007/978-1-4939-7404-7_2 ◽

2017 ◽

pp. 25-59 ◽

Cited By ~ 2

Author(s):

Sergi Gómez-Ganau ◽

Jesús Vicente de Julián-Ortiz ◽

Rafael Gozalbes

Keyword(s):

Computational Approaches ◽

Recent Advances

Download Full-text

Galantamine Derivatives as Acetylcholinesterase Inhibitors: Docking, Design, Synthesis, and Inhibitory Activity

Neuromethods - Computational Modeling of Drugs Against Alzheimer’s Disease ◽

10.1007/978-1-4939-7404-7_6 ◽

2017 ◽

pp. 163-176 ◽

Cited By ~ 1

Author(s):

Irini Doytchinova ◽

Mariyana Atanasova ◽

Georgi Stavrakov ◽

Irena Philipova ◽

Dimitrina Zheleva-Dimitrova

Keyword(s):

Inhibitory Activity ◽

Acetylcholinesterase Inhibitors ◽

Design Synthesis

Download Full-text

Modeling of BACE-1 Inhibitors as Anti-Alzheimer’s Agents

Neuromethods - Computational Modeling of Drugs Against Alzheimer’s Disease ◽

10.1007/978-1-4939-7404-7_7 ◽

2017 ◽

pp. 177-206

Author(s):

Odailson Santos Paz ◽

Thamires Quadros Froes ◽

Franco Henrique Leite ◽

Marcelo Santos Castilho

Keyword(s):

Bace 1

Download Full-text

Virtual Screening in the Search of New and Potent Anti-Alzheimer Agents

Neuromethods - Computational Modeling of Drugs Against Alzheimer’s Disease ◽

10.1007/978-1-4939-7404-7_4 ◽

2017 ◽

pp. 107-137 ◽

Cited By ~ 4

Author(s):

Livia Basile

Keyword(s):

Virtual Screening

Download Full-text

Neuropharmacology in Flux: Molecular Modeling Tools for Understanding Protein Conformational Shifts in Alzheimer’s Disease and Related Disorders

Neuromethods - Computational Modeling of Drugs Against Alzheimer’s Disease ◽

10.1007/978-1-4939-7404-7_20 ◽

2017 ◽

pp. 573-611

Author(s):

Gerald H. Lushington ◽

Frances E. S. Parker ◽

Thomas H. W. Lushington ◽

Nora M. Wallace

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Molecular Modeling ◽

Modeling Tools ◽

Conformational Shifts

Download Full-text

Computational Approaches for Therapeutic Application of Natural Products in Alzheimer’s Disease

Neuromethods - Computational Modeling of Drugs Against Alzheimer’s Disease ◽

10.1007/978-1-4939-7404-7_17 ◽

2017 ◽

pp. 483-511 ◽

Cited By ~ 2

Author(s):

Manika Awasthi ◽

Swati Singh ◽

Sameeksha Tiwari ◽

Veda P. Pandey ◽

Upendra N. Dwivedi

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Natural Products ◽

Therapeutic Application ◽

Computational Approaches

Download Full-text

In Silico Strategies to Design Small Molecules to Study Beta-Amyloid Aggregation

Neuromethods - Computational Modeling of Drugs Against Alzheimer’s Disease ◽

10.1007/978-1-4939-7404-7_10 ◽

2017 ◽

pp. 249-261

Author(s):

Praveen P. N. Rao ◽

Deguo Du

Keyword(s):

Small Molecules ◽

In Silico ◽

Beta Amyloid ◽

Amyloid Aggregation

Download Full-text

Computational Approaches to Understand Cleavage Mechanism of Amyloid Beta (Aβ) Peptide

Neuromethods - Computational Modeling of Drugs Against Alzheimer’s Disease ◽

10.1007/978-1-4939-7404-7_11 ◽

2017 ◽

pp. 263-282

Author(s):

Kailas Dashrath Sonawane ◽

Maruti Jayaram Dhanavade

Keyword(s):

Amyloid Beta ◽

Aβ Peptide ◽

Computational Approaches

Download Full-text

In Silico Studies Applied to Natural Products with Potential Activity Against Alzheimer’s Disease

Neuromethods - Computational Modeling of Drugs Against Alzheimer’s Disease ◽

10.1007/978-1-4939-7404-7_18 ◽

2017 ◽

pp. 513-531 ◽

Cited By ~ 4

Author(s):

Luciana Scotti ◽

Marcus T. Scotti

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Natural Products ◽

In Silico ◽

In Silico Studies ◽

Potential Activity

Download Full-text

Molecular Modeling of Tau Proline-Directed Protein Kinase (PDPK) Inhibitors

Neuromethods - Computational Modeling of Drugs Against Alzheimer’s Disease ◽

10.1007/978-1-4939-7404-7_13 ◽

2017 ◽

pp. 305-345 ◽

Cited By ~ 2

Author(s):

Carlos Navarro-Retamal ◽

Julio Caballero

Keyword(s):

Molecular Modeling ◽

Protein Kinase

Download Full-text

Neuromethods - Computational Modeling of Drugs Against Alzheimer’s DiseaseLatest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Springer New York

Recent Advances in Computational Approaches for Designing Potential Anti-Alzheimer’s Agents

Galantamine Derivatives as Acetylcholinesterase Inhibitors: Docking, Design, Synthesis, and Inhibitory Activity

Modeling of BACE-1 Inhibitors as Anti-Alzheimer’s Agents

Virtual Screening in the Search of New and Potent Anti-Alzheimer Agents

Neuropharmacology in Flux: Molecular Modeling Tools for Understanding Protein Conformational Shifts in Alzheimer’s Disease and Related Disorders

Computational Approaches for Therapeutic Application of Natural Products in Alzheimer’s Disease

In Silico Strategies to Design Small Molecules to Study Beta-Amyloid Aggregation

Computational Approaches to Understand Cleavage Mechanism of Amyloid Beta (Aβ) Peptide

In Silico Studies Applied to Natural Products with Potential Activity Against Alzheimer’s Disease

Molecular Modeling of Tau Proline-Directed Protein Kinase (PDPK) Inhibitors

Neuromethods - Computational Modeling of Drugs Against Alzheimer’s Disease
Latest Publications